Home › Sarcoidosis › NCT07604220

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria

* Adults ≥18 years.
* Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
* Undergoing FDG-PET as part of standard care.
* Ability to provide informed consent.

Exclusion Criteria

• Inability to provide informed consent.

About the study

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

What is being tested

• Exosome Analysis (other)

Sponsor: Mayo Clinic · Participants: 115 · Started: Jul 13, 2026

Contact the study team

• Anna Pick · Phone: 507-255-0630

Official record on ClinicalTrials.gov — NCT07604220

Locations in the U.S.

Conditions

• Sarcoidosis

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.